Back to Citadel Advisors LLC Citadel Advisors LLC

ICCM

Showing 4 of 10 quarters

Position history for Citadel Advisors LLCCitadel Advisors LLC's holdings in IceCure Medical Ltd.

No. Citadel Advisors exited its ICCM (IceCure Medical) position in Q4 2025. Its Q3 2025 13F listed 37,173 shares worth $37,916. Citadel Advisors first reported ICCM in Q1 2022 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$18.30
0
2025-Q3
Decreased
37,173
-29.2%
$37,9160.0%$30.45
0
2025-Q2
New
52,524
-
$52,2880.0%$29.88
32
2024-Q3
Exited
0
-100.0%
$00.0%$18.30
0

Other major holders of ICCM: ARK Investment Management LLC, Jane Street Group, LLC, Bank of America Corp.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used